posted on 2023-05-18, 00:05authored byDahiya, A, Vollbon, W, Jellis, C, Prior, D, Wahi, S, Thomas MarwickThomas Marwick
<b>Objective</b> To optimise an echocardiographic estimation of pulmonary vascular resistance (PVR<sub>e</sub>) for diagnosis and follow-up of pulmonary hypertension (PHT).<br> <b>Design</b> Cross-sectional study.<br> <b>Setting</b> Tertiary referral centre.<br> <b>Patients</b> Patients undergoing right heart catheterisation and echocardiography for assessment of suspected PHT.<br> <b>Methods</b> PVR<sub>e</sub> ([tricuspid regurgitation velocity X10/ (right ventricular outflow tract velocity-time integral +0.16) and invasive PVR<sub>i</sub> ((mean pulmonary artery systolic pressure-wedge pressure)/cardiac output) were compared in 72 patients. Other echo data included right ventricular systolic pressure (RVSP), estimated right atrial pressure, and E/e' ratio. Difference between PVR<sub>e</sub> and PVR<sub>i</sub> at various levels of PVR was sought using Blande-Altman analysis. Corrected PVR<sub>c</sub> ((RVSP-E/e')/ RVOT<sub>VTI</sub>) (RVOT, RV outflow time; VTI, velocity time integral) was developed in the training group and tested in a separate validation group of 42 patients with established PHT.<br> <b>Results</b> PVR<sub>e</sub>>2.0 had high sensitivity (93%) and specificity (91%) for recognition of PVR<sub>i</sub>>2.0, and PVR<sub>c</sub> provided similar sensitivities and specificities. PVR<sub>e</sub> and PVR<sub>i</sub> correlated well (r=0.77, p<0.01), but PVR<sub>e</sub> underestimated marked elevation of PVR<sub>i</sub>-a trend avoided by PVR<sub>c</sub>. PVR<sub>c</sub> and PVR<sub>e</sub> were tested against PVR<sub>i</sub> in a separate <i>validation group</i> (n=42). The mean difference between PVR<sub>e</sub> and PVR<sub>i</sub> exceeded that between PVR<sub>c</sub> and PVR<sub>i</sub> (2.8+-2.7 vs 0.8+-3.0 Wood units; p<0.001). A drop in PVR<sub>i</sub> by at least one SD occurred in 10 patients over 6 months; this was detected in one patient by PVR<sub>e</sub> and eight patients by PVR<sub>c</sub> (p=0.002).<br> <b>Conclusion</b> PVR<sub>e</sub> distinguishes normal from abnormal PVR<sub>i</sub> but underestimates high PVR<sub>i</sub>. PVR<sub>c</sub> identifies the severity of PHT and may be used to assess treatment response.